Yeshiva World News · Oct 22, 2026
Yeshiva World News — photo status
Moderna shares plunged about 23% after results from its experimental cancer vaccine study surfaced, despite showing reduced risks of melanoma spread by 38% and recurrence or death by 42%. Investors had expected stronger results; full findings are due Saturday.
More from Yeshiva World News
- Yeshiva World NewsNov 4, 2026 · DeSantis: This midterm was a rebuke of the president and the
- Yeshiva World NewsNov 4, 2026 · DeSantis: If we can't win in places like Texas or Kansas or
- Yeshiva World NewsNov 4, 2026 · Mayor Zohran Mamdani has directed NYPD and City Hall officia
- Yeshiva World NewsNov 4, 2026 · IDF Chief of Staff Lt. Gen. Eyal Zamir made an unprecedented
- Yeshiva World NewsNov 4, 2026 · Iran says the Strait of Hormuz will reopen only after Washin
- Yeshiva World NewsNov 4, 2026 · President Trump criticized the Senate for failing to pass le
